IMPACTNCT06644963
IMPELLA, Complications and Tolerance
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Minor Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting
- Study First Submitted
- Minor: routine updates
Endpoints
Primary
Hemocompatibility related adverse events (HRAEs)
Timeframe: From start of hospitalization until hospital discharge, assessed up to 3 month
Secondary (5)
Early mortality
Adverse events related to Impella devices
Duration of mechanical ventilation
Lengh of stay
Cardiac long-term project
Arms and interventions
Devices: Impella (5, 5.5 or CP)
Sites
1 site in 1 country
- Montpellier university hospitalMontpellier, France